Human embryonic stem cells differentiated to various cell types, including (clockwise, from upper left) gut, neural, striated muscle, and kidney cells. CREDIT: J. A. THOMSON We the undersigned urge the Administration and DHHS to support Varmus's decision to allow federal funds to be used for research using human pluripotent stem cells. NIH fully understands and respects the important ethical and moral issues raised by stem cell research and, indeed, has announced plans "to move forward in a careful and deliberate fashion to develop rigorous guidelines that address the special ethical, legal, and moral issues surrounding this research." Before funding any research using pluripotent stem cells, NIH plans to convene a special oversightgroup to review all research grant applications in this area. In addition to two thoughtful sets of guidelines that already exist--the 1994 Report of the Human Embryo Research Panel and the regulations regarding Research on Transplantation of Fetal Tissue (section 498A of the Public Health Services Act)--NIH will consider advice from the National Bioethics Advisory Commission (NBAC), the newly established Council of Public Representatives (COPR), the public, and Congress.
We join with other scientific organizations and patient groups in our belief that DHHS's current position is both laudable and forward-thinking. It succeeds in protecting the sanctity of human life without impeding biomedical research that could be profoundly important to the understanding and treatment of human disease. In addition to helping to unravel processes underlying cell differentiation and biological development (which, in turn, could lead to new ways to prevent and treat birth defects and cancer), the use of human pluripotent stem cells could potentially reduce the number of animal studies and clinical trials required for drug development and testing. The implications of this research for clinical medicine are equally enormous. Stem cells could be used to generate a long list of cells and tissues that could be used for transplantation. Myocardiocytes, for instance, could be injected into the heart, to heal myopathies and scars; neurons could be transplanted into the brains of patients with neurodegenerative disorders such as Parkinson's disease; and insulin-producing beta cells could be used to treat--or perhaps even cure--patients with diabetes. DHHS must remain diligent in allowing pluripotent stem cell research to go forward. If Congress succeeds in reversing Varmus's decision, these
